iiinova — where your digital self keeps evolving

Teja Kulkarni @tkulkarni.bsky.social · 04/04/2026

Excited to share our review “Challenging the Status Quo for Therapeutic Clinical Trials in Fibrotic Interstitial Lung Diseases” where we discuss the current clinical trial landscape and explore emerging strategies to accelerate the development of therapies for fILD. lnkd.in/guuRdp-w #ILD #curePF

000

Reposted by Teja Kulkarni

Kerri Johannson MD MPH @kerrijohannson.bsky.social · 31/03/2026

🌟 Save the Date! 🌟 Calgary International Microbiome Summit Oct 5-7, 2027 in Calgary, Canada 🦠🧫🧪🧬🔬🤩 Hosted by @snyderinstitute.bsky.social & @ucalgarymed.bsky.social It’s basically the Microbiome Olympics

242

Teja Kulkarni @tkulkarni.bsky.social · 12/11/2025

The “why” behind every decision is the person in front of us. In this conversation, I joined the Leap Together podcast to discuss the real-world complexity for patients living with pulmonary fibrosis. Listen here: lpcur.com/LeapTogether... #LeapTogetherPodcast #ClinicalTrials #curePF

021

Reposted by Teja Kulkarni

Kerri Johannson MD MPH @kerrijohannson.bsky.social · 14/10/2025

The Impact of Pulmonary Fibrosis on Sex and Sexual Function - A Multinational Mixed Methods Study Just out in ERJ and led by Dr. Na'ama Avitzur A 🧵👇 (key take-away 👉 sex matters to patients with PF and their disease impacts this) #OpenAccess #CurePF #CureIPF publications.ersnet.org/content/erj/...

1164

Teja Kulkarni @tkulkarni.bsky.social · 09/10/2025

The approval of Nerandomilast marks a pivotal step forward in IPF care. For patients living with IPF, this offers long awaited hope and this milestone underscores the collective efforts of multiple stakeholders who never stopped pushing for better therapeutic options for IPF.

010

Reposted by Teja Kulkarni

KaminskiMed @kaminskimed.bsky.social · 08/10/2025

Yesterday, the U.S. FDA approved Jascayd (nerandomilast) to treat IPF. This is the first IPF new therapy approved in more than a decade. Congratulations to all our patients & yes, better drugs are on the way!! Great day for the #CureIPF community!! #ScienceMatters www.fda.gov/drugs/news-e...

fda.gov

FDA approves drug to treat idiopathic pulmonary fibrosis

First new treatment in more than a decade for rare lung condition

062

Reposted by Teja Kulkarni

Kerri Johannson MD MPH @kerrijohannson.bsky.social · 02/09/2025

TETON-2 phase 2 RCT of nebulized treprostinil for IPF 🫁 Positive trial 🗞️ Change in FVC at 52 weeks difference of 95.6mL (!), and 2* endpoints like K-BILD @ipfdoc.bsky.social @kaminskimed.bsky.social @tkulkarni.bsky.social @jskim8223.bsky.social www.theglobeandmail.com/investing/ma...

174

Reposted by Teja Kulkarni

Kerri Johannson MD MPH @kerrijohannson.bsky.social · 12/05/2025

Heading to #ATS2025 🫁? Wondering about the Clinical Problems assembly content? 📻 Check out this podcast where we break it down for you 👇😁 @ats-clinicalprobs.bsky.social @atsearlycareer.bsky.social

064

Reposted by Teja Kulkarni

KaminskiMed @kaminskimed.bsky.social · 03/03/2025

Exactly. Think about it - what if this drug improves FVC - what would the patients’ risk tolerance be?

021

Reposted by Teja Kulkarni

ATS Clinical Problems Assembly @ats-clinicalprobs.bsky.social · 16/01/2025

The ATS CP apprenticeship program is a great way to get involved with the assembly! Get more info and apply here: tinyurl.com/439v6xam Make sure to select the clinical problems assembly and apply before January 24!⏰ #pulmsky #medsky

tinyurl.com

American Thoracic Society | ATS Apprenticeship Program

The American Thoracic Society is the world's leading medical society dedicated to accelerating the advancement of global respiratory health through…

044

Reposted by Teja Kulkarni

Kerri Johannson MD MPH @kerrijohannson.bsky.social · 04/01/2025

🌟 Impact of Environmental Exposures on the Development and Progression of Fibrotic Interstitial Lung Disease 🌟 Just out in @atsblueeditor.bsky.social 🫁 www.atsjournals.org/doi/abs/10.1... State of the Art: -Epidemiology -Mechanisms of Injury -Implications - clinical & policy -Future directions

Screenshot of the article title and authors

1216

Reposted by Teja Kulkarni

Kerri Johannson MD MPH @kerrijohannson.bsky.social · 21/12/2024

Now can we use CA-125 as a theragnostic biomarker of treatment response in patients with IPF? Why wouldn't we? @ipfdoc.bsky.social @kaminskimed.bsky.social #CurePF #CureIPF @ats-clinicalprobs.bsky.social @tkulkarni.bsky.social @jskim8223.bsky.social pmc.ncbi.nlm.nih.gov/articles/pmi...

screenshot of study title. Effects of nintedanib on biomarkers in IPF in ERJ Open.

2106

Teja Kulkarni @tkulkarni.bsky.social · 05/12/2024

An excellent 🧵on potential application of Mendelian randomization towards target identification and therapeutic development #cureIPF #REMAP-ILD

031

Reposted by Teja Kulkarni

Chris Carroll, MD @chriscarrollmd.com · 03/12/2024

There’s still time to submit session ideas for #CHEST2025! Don't miss your chance to speak! Need help? Just ask me! info.chestnet.org/chest-call-f...

251

Teja Kulkarni @tkulkarni.bsky.social · 21/11/2024

Among other factors, this real-world study underscores the importance of addressing mental health in patients with IPF #curePF

011

Reposted by Teja Kulkarni

Rabin @rabinperspective.bsky.social · 21/11/2024

Continued awareness and identification of IPF needs to continue.

021

Reposted by Teja Kulkarni

Gísli @ipfdoc.bsky.social · 19/11/2024

So excited to hear what @kerrijohannson.bsky.social has to tell us about the impact of our environment on the development of pulmonary fibrosis! The whole lecture will be available on-line via the MTW website: www.imperial.ac.uk/mtw-centre-f...

262

Reposted by Teja Kulkarni

KaminskiMed @kaminskimed.bsky.social · 16/11/2024

Really cool! our “Single-Cell Analysis Reveals Novel Immune Perturbations in Fibrotic Hypersensitivity Pneumonitis” made it to cover of the American Journal of Respiratory & Critical Care Medicine. Kudos to soon to be #DoubleDoc Amy Zhao & crew!! #BestStudents www.atsjournals.org/doi/full/10....

1255

Reposted by Teja Kulkarni

Brad Bemiss @bbpulmdoc.bsky.social · 13/11/2024

Made my first pilgrimage to ACCP in Glenview, IL this week. Thanks #Chest for the hospitality! @tkulkarni.bsky.social

041